Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00181831 · ClinicalTrials.gov registry record
Spectroscopy in Children and Adolescents With Bipolar Disorder
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 80
- Enrollment target
NCT00181831: Completed study, sponsored by Massachusetts General Hospital.
NCT00181831 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00181831 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The primary aim of this study is to use proton magnetic resonance spectroscopy to look at myo-Inositol containing compounds (Ino) and creatine + phosphocreatine (Cr) in the anterior cingulate of 20 children with bipolar disorder between the ages of 6-17 years old free of risperidone treatment and 20 children with bipolar disorder after an eight-week or longer treatment with risperidone. For comparison, results will also be obtained from 20 controls (without bipolar disorder or ADHD) of the same age and gender as well as from 20 children or adolescents with a diagnosis of Attention Deficit Hyperactivity Disorder. We hypothesize that Ino/Cr levels in the anterior cingulate will correlate positively with manic symptoms using the Young mania rating scale (YMRS). Ino/Cr levels in the anterior cingulate in the anterior cingular gyrus will be lower in subjects who have received eight weeks or longer of risperidone
Interventions
- DEVICE Proton Magnetic Resonance Spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2002-12 |
| Est. Completion | 2005-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00181831
The ClinicalTrials.gov registry entry for NCT00181831 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proton Magnetic Resonance Spectroscopy is the first listed.
NCT00181831 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00181831 about?
NCT00181831 is a clinical study titled "Spectroscopy in Children and Adolescents With Bipolar Disorder". The primary aim of this study is to use proton magnetic resonance spectroscopy to look at myo-Inositol containing compounds (Ino) and creatine + phosphocreatine (Cr) in the anterior cingulate of 20 children with bipolar disorder between the ages of 6-17 years old free of risperidone treatment and 20...
What is the current status of trial NCT00181831?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2002-12. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00181831?
The interventions under investigation include: Proton Magnetic Resonance Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00181831?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.